 It is a prospective randomized single-blinded monocentric study including 150 patients undergoing hip fracture surgery within 72 h after trauma aged 60 years divided in 3 groups: Group A IV ferTranexamic acid, Group B Tranexamic acid, Group C placebo. The main outcome was percentage of patients who receive red-cell transfusion during hospitalization. Hemoglobin levels up to 60 days post-operatively and incidence of thrombotic events were secondary outcomes. 